Baker Bros. Advisors’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-8,565
| Closed | -$18.8K | – | 113 |
|
|
2022
Q4 | $18.8K | Sell |
8,565
-192,796
| -96% | -$422K | ﹤0.01% | 113 |
|
|
2022
Q3 | $604K | Sell |
201,361
-173,034
| -46% | -$519K | ﹤0.01% | 103 |
|
|
2022
Q2 | $1.06M | Sell |
374,395
-250,605
| -40% | -$710K | 0.01% | 101 |
|
|
2022
Q1 | $3.34M | Hold |
625,000
| – | – | 0.02% | 96 |
|
|
2021
Q4 | $4.67M | Hold |
625,000
| – | – | 0.02% | 95 |
|
|
2021
Q3 | $5.68M | Buy |
+625,000
| New | +$5.68M | 0.02% | 91 |
|
|
2016
Q2 | – | Sell |
-152,686
| Closed | -$8.42M | – | 139 |
|
|
2016
Q1 | $8.42M | Sell |
152,686
-14,109
| -8% | -$778K | 0.09% | 62 |
|
|
2015
Q4 | $23M | Hold |
166,795
| – | – | 0.19% | 39 |
|
|
2015
Q3 | $24M | Hold |
166,795
| – | – | 0.22% | 37 |
|
|
2015
Q2 | $43.2M | Buy |
+166,795
| New | +$43.2M | 0.38% | 29 |
|